Eisai Pharma AG is a research and development-oriented pharmaceutical company specializing in the research, development, and distribution of products in the fields of neurology and oncology. The company's core activity is the development and provision of innovative treatment options for patients with severe illnesses, particularly in the fields of neurology and oncology.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered4
Medicines for Neurology
Medicines and treatment options for neurological diseases, in particular Alzheimer’s dementia and epilepsy; sales and market supply for the Swiss market.
Medicines for Oncology
Medicines and therapy approaches for cancers with a high unmet medical need; used, among others, in breast cancer, endometrial cancer, liver cancer, kidney cancer, liposarcoma and thyroid cancer.
Research and Development
Drug substance research, pharmaceutical development and clinical research focused on neurology and oncology; aimed at new treatment options with a high therapeutic need.
Sales and Marketing of Pharmaceutical Products
Sales, marketing and promotion of medicines for the Swiss market; employees also work in medical affairs, regulatory affairs, finance and pharmaceutical services.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.